- Monografía Avanzaten
- Bianchi, R., Giambanco, I., & Donato, R. (2010). S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiology of aging, 31(4), 665–677.
- Donato R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. The international journal of biochemistry & cell biology, 33(7), 637–668.
- Bergh, C. D., Bäckström, M., Axelsson, K., Jönsson, H., & Johnsson, P. (2007). Protein S100B after cardiac surgery: an indicator of long-term anxiety?. Scandinavian cardiovascular journal: SCJ, 41(2), 109–113.
- Rothermundt, M., Arolt, V., Wiesmann, M., Missler, U., Peters, M., Rudolf, S., & Kirchner, H. (2001). S-100B is increased in melancholic but not in non-melancholic major depression. Journal of affective disorders, 66(1), 89–93.
- Parfenov, V.A., Kamchatnov, P.R., Khasanova, D.R. et al. The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders. Sci Rep 11, 24282 (2021).
- Xia, C., Braunstein, Z., Toomey, A. C., Zhong, J., & Rao, X. (2018). S100 Proteins As an Important Regulator of Macrophage Inflammation. Frontiers in immunology, 8, 1908.
- Labclinics. (2022). Polyclonal vs. Monoclonal antibodies. www.labclinics.com.
- S. Stapleton, R. O' Kennedy, E. Tully. (2005). IMMUNOASSAYS | Production of Antibodies. Encyclopedia of Analytical Science (Second Edition), Elsevier, Pages 306-316, ISBN 9780123693976.
- Monografía Anaferon
- Script Video tabletas orodispersables (Consultar *11. Script Video tabletas orodispersables)
*11. Script Video tabletas orodispersables
- Lam, J. K., Xu, Y., Worsley, A., & Wong, I. C. (2014). Oral transmucosal drug delivery for pediatric use. Advanced drug delivery reviews, 73, 50–62. https://doi.org/10.1016/j.addr.2013.08.011
- Hearnden, V., Sankar, V., Hull, K., Juras, D. V., Greenberg, M., Kerr, A. R., Lockhart, P. B., Patton, L. L., Porter, S., & Thornhill, M. H. (2012). New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Advanced drug delivery reviews, 64(1), 16–28. https://doi.org/10.1016/j.addr.2011.02.008
- Roy, A. (2016). ORODISPERSIBLE TABLETS: A REVIEW. Asian Journal of Pharmaceutical and Clinical Research, 9(1), 19–26. Retrieved from https://innovareacademics.in/journals/index.php/ajpcr/article/view/9029
- Patel, V. F., Liu, F., & Brown, M. B. (2011). Advances in oral transmucosal drug delivery. Journal of controlled release: official journal of the Controlled Release Society, 153(2), 106–116. https://doi.org/10.1016/j.jconrel.2011.01.027
- Zhang, H., Zhang, J., & Streisand, J. B. (2002). Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clinical pharmacokinetics, 41(9), 661–680. https://doi.org/10.2165/00003088-200241090-00003
- Dey, P., & Maiti, S. (2010). Orodispersible tablets: A new trend in drug delivery. Journal of natural science, biology, and medicine, 1(1), 2–5. https://doi.org/10.4103/0976-9668.71663
- IPPA ANAFERON